NIST recently released the Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile (NIST-AI-600-1). This framework was developed to assist organizations in identifying the specific […]
FDA’s Troy Tazbaz, Director, and John Nicol, PhD, Digital Health Specialist at the FDA’s Digital Health Center of Excellence (DHCoE), recently proposed “A Lifecycle Management
FDA Proposes AI Lifecycle Management Framework Read More »
To encourage the use of Nanomaterials in medical products, the FDA published guidance for the industry on “Drug Products, Including Biological Products, that Contain Nanomaterials.” Given
AsssurX Briefing Note Axendia was recently briefed by Stephanie Ojeda, Director of Product Management, Life Sciences and Manufacturing and Sal Lucido, Executive VP and Co-Founder
Appian Briefing Note Axendia was recently briefed by Evi Cohen, Global Industry Leader, Life Sciences, along with Nicholas Costa, Analyst Relations Manager; Andres Carrillo, Director,
Empowering Life Sciences with an AI-Powered Unified Automation Platform Read More »
